BioLert Gets Epilepsy Grant
The American Epilepsy Research Foundation (ERF) has awarded BioLert Ltd. the developer of Epilert a grant of $130,000 to assist in the development of a device for the portable monitoring of epilepsy seizures by patients, reports BioLert CEO Amos Shaham. The EpiLert Seizure Alert Device comprises a bracelet that automatically sends an alert signal to caregivers when a patient suffers an epileptic seizure. By immediately alerting caregivers of a seizure, the EpiLert can save lives, or prevent severe brain damage, in patients suffering prolonged attacks that require medical intervention. The EpiLert enables patients to lead normal lives and provides peace-of-mind for family members, especially the parents of child patients, who can be assured that their children are being monitored around-the-clock. The Epilepsy Research Foundation was created through a partnership between the Epilepsy Foundation, the Epilepsy Therapy Development Project (formerly The Epilepsy Project) and Finding a Cure for Epilepsy and Seizures (FACES). The mission of the Epilepsy Research Foundation is to fund new research avenues seeking a cure for epilepsy and to support the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient.